Insider Transactions in Q2 2020 at Ultragenyx Pharmaceutical Inc. (RARE)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2020
|
Erik Harris EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,516
-10.77%
|
$186,184
$74.69 P/Share
|